Market Cap 6.72M
Revenue (ttm) 70,000.00
Net Income (ttm) 400,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 571.43%
Debt to Equity Ratio 0.00
Volume 9,900
Avg Vol 15,944
Day's Range N/A - N/A
Shares Out 996,000.00
Stochastic %K 10%
Beta 0.64
Analysts Sell
Price Target $16.00

Company Profile

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precance...

Industry: Medical Devices
Sector: Healthcare
Phone: 917 813 1828
Address:
360 Madison Avenue, 25th Floor, New York, United States
Thegame7000
Thegame7000 May. 13 at 10:50 AM
0 · Reply
mlwtwits
mlwtwits May. 12 at 7:25 PM
$PAVM I bought back in a few once again. Waiting for the Upper $5 range to buy more.
0 · Reply
chuckjackson
chuckjackson May. 12 at 3:58 PM
$PAVM this all makes sense. They refinaced to investors like Ayrton at a cost basis of (or below). These investors are flippers who will sell as soon as possible and aren't going to wait for the draft. They will pin this stock down and sell anytime the bid pops above $6.50. We need the draft. Even with the draft or this is dead money. @Investor_Scale
3 · Reply
dmscott2008
dmscott2008 May. 12 at 2:38 PM
$PAVM at 6.50. Time for news, let the shares be flooded at 6.5 and away we go
0 · Reply
Investor_Scale
Investor_Scale May. 12 at 2:33 PM
$PAVM very odd
0 · Reply
Investor_Scale
Investor_Scale May. 12 at 2:32 PM
$PAVM no buyers below $7 ?!?
0 · Reply
MagiCarpX
MagiCarpX May. 12 at 11:07 AM
$PAVM once you treat investing like going to a casino you care less 😆😂. Thats all individual stocks are these days.
0 · Reply
chuckjackson
chuckjackson May. 12 at 3:30 AM
0 · Reply
chuckjackson
chuckjackson May. 12 at 12:57 AM
$PAVM maybe these fokkers are the reason for the declining stock price Ayrton Capital LLC (and its associated Alto Opportunity Funds) typically operates as an absolute-return hedge fund that focuses on "toxic" or highly structured financing, which often leads to a "flip" rather than a long-term "hold" strategy. ​Based on their SEC filings and market activity, here is a breakdown of their typical behavior: ​1. The Financing Structure (Convertibles and Warrants) ​Ayrton frequently invests in micro-cap and small-cap companies (like Lucid Diagnostics (LUCD), ToughBuilt (TBLT), and ESS Tech (GWH)) through convertible notes, preferred stock, or warrants. ​They often receive shares at a significant discount to the market price or via "floorless" convertibles. ​The "Flip": Once the registration statement (like an S-3 or 424B) becomes effective, they typically sell the underlying shares into the market to capture the spread between their discounted entry price and the current trading
2 · Reply
chuckjackson
chuckjackson May. 12 at 12:32 AM
$PAVM I've been pretty nonchalant about this but it has literally faded to almost $6.50. The drop from $10 to $6.75 is a drop of 32.5% which isn't chump change. Should I have sold instead of wait for the draft? Lishan, if this goes below $6.50, all the warrants become worthless and your $30M funding evaporates. Better hold off on the new spending until the draft comes through.
1 · Reply
Latest News on PAVM
PAVmed files to sell 9.23M shares of common stock for holders

2026-04-21T10:05:12.000Z - 22 days ago

PAVmed files to sell 9.23M shares of common stock for holders


PAVmed price target lowered to $16 from $60 at Maxim

2026-03-31T13:35:59.000Z - 6 weeks ago

PAVmed price target lowered to $16 from $60 at Maxim


PAVmed price target lowered to $16 from $60 at Maxim

2026-03-31T13:28:31.000Z - 6 weeks ago

PAVmed price target lowered to $16 from $60 at Maxim


PAVmed Earnings Call Transcript: Q4 2025

Mar 30, 2026, 8:30 AM EDT - 6 weeks ago

PAVmed Earnings Call Transcript: Q4 2025


PAVmed trading resumes

2026-02-02T14:45:30.000Z - 3 months ago

PAVmed trading resumes


PAVmed trading halted, volatility trading pause

2026-02-02T14:40:49.000Z - 3 months ago

PAVmed trading halted, volatility trading pause


PAVmed trading resumes

2026-01-21T14:45:24.000Z - 3 months ago

PAVmed trading resumes


PAVmed trading halted, volatility trading pause

2026-01-21T14:40:50.000Z - 3 months ago

PAVmed trading halted, volatility trading pause


Huge Win for PAVmed (PAVM) Sends Shares Surging

2026-01-21T14:36:25.000Z - 3 months ago

Huge Win for PAVmed (PAVM) Sends Shares Surging


PAVmed trading halted, news pending

2026-01-01T00:50:31.000Z - 4 months ago

PAVmed trading halted, news pending


PAVmed announces 1-for-30 reverse stock split

2025-12-30T14:10:18.000Z - 4 months ago

PAVmed announces 1-for-30 reverse stock split


PAVmed Announces Reverse Stock Split

Dec 30, 2025, 9:01 AM EST - 4 months ago

PAVmed Announces Reverse Stock Split


PAVmed Earnings Call Transcript: Q3 2025

Nov 13, 2025, 8:30 AM EST - 6 months ago

PAVmed Earnings Call Transcript: Q3 2025


PAVmed reports Q2 non-GAAP EPS (5c) vs. (84c) last year

2025-08-14T12:05:15.000Z - 9 months ago

PAVmed reports Q2 non-GAAP EPS (5c) vs. (84c) last year


PAVmed Earnings Call Transcript: Q2 2025

Aug 13, 2025, 8:30 AM EDT - 9 months ago

PAVmed Earnings Call Transcript: Q2 2025


PAVmed Earnings Call Transcript: Q1 2025

May 15, 2025, 8:30 AM EDT - 1 year ago

PAVmed Earnings Call Transcript: Q1 2025


PAVmed reports Q4 adjusted EPS (6c) vs. ($1.33) last year

2025-03-25T18:42:22.000Z - 1 year ago

PAVmed reports Q4 adjusted EPS (6c) vs. ($1.33) last year


PAVmed Earnings Call Transcript: Q4 2024

Mar 25, 2025, 8:30 AM EDT - 1 year ago

PAVmed Earnings Call Transcript: Q4 2024


Thegame7000
Thegame7000 May. 13 at 10:50 AM
0 · Reply
mlwtwits
mlwtwits May. 12 at 7:25 PM
$PAVM I bought back in a few once again. Waiting for the Upper $5 range to buy more.
0 · Reply
chuckjackson
chuckjackson May. 12 at 3:58 PM
$PAVM this all makes sense. They refinaced to investors like Ayrton at a cost basis of (or below). These investors are flippers who will sell as soon as possible and aren't going to wait for the draft. They will pin this stock down and sell anytime the bid pops above $6.50. We need the draft. Even with the draft or this is dead money. @Investor_Scale
3 · Reply
dmscott2008
dmscott2008 May. 12 at 2:38 PM
$PAVM at 6.50. Time for news, let the shares be flooded at 6.5 and away we go
0 · Reply
Investor_Scale
Investor_Scale May. 12 at 2:33 PM
$PAVM very odd
0 · Reply
Investor_Scale
Investor_Scale May. 12 at 2:32 PM
$PAVM no buyers below $7 ?!?
0 · Reply
MagiCarpX
MagiCarpX May. 12 at 11:07 AM
$PAVM once you treat investing like going to a casino you care less 😆😂. Thats all individual stocks are these days.
0 · Reply
chuckjackson
chuckjackson May. 12 at 3:30 AM
0 · Reply
chuckjackson
chuckjackson May. 12 at 12:57 AM
$PAVM maybe these fokkers are the reason for the declining stock price Ayrton Capital LLC (and its associated Alto Opportunity Funds) typically operates as an absolute-return hedge fund that focuses on "toxic" or highly structured financing, which often leads to a "flip" rather than a long-term "hold" strategy. ​Based on their SEC filings and market activity, here is a breakdown of their typical behavior: ​1. The Financing Structure (Convertibles and Warrants) ​Ayrton frequently invests in micro-cap and small-cap companies (like Lucid Diagnostics (LUCD), ToughBuilt (TBLT), and ESS Tech (GWH)) through convertible notes, preferred stock, or warrants. ​They often receive shares at a significant discount to the market price or via "floorless" convertibles. ​The "Flip": Once the registration statement (like an S-3 or 424B) becomes effective, they typically sell the underlying shares into the market to capture the spread between their discounted entry price and the current trading
2 · Reply
chuckjackson
chuckjackson May. 12 at 12:32 AM
$PAVM I've been pretty nonchalant about this but it has literally faded to almost $6.50. The drop from $10 to $6.75 is a drop of 32.5% which isn't chump change. Should I have sold instead of wait for the draft? Lishan, if this goes below $6.50, all the warrants become worthless and your $30M funding evaporates. Better hold off on the new spending until the draft comes through.
1 · Reply
traderjoe2018
traderjoe2018 May. 11 at 10:43 PM
$PAVM it makes me feel so good inside to realize how much money I pissed away in this shitty stock. Management is absolutely useless. Just destroying the retail investors while they pad their pockets. I’m just hoping for some kind of bump so I can finally get out. I will never recoup what I have lost. I genuinely feel sorry for all of us long holders. $LUCD could help but I won’t hold my breath.
3 · Reply
Tom__Brady
Tom__Brady May. 11 at 10:32 PM
$PAVM Ayrton ☠️
1 · Reply
chuckjackson
chuckjackson May. 11 at 7:27 PM
$PAVM my happiness will depend on the stock price. Specifically for pavm, the chances of a large spike have reduced significantly. My guess is they will sell into the rally to capture reasonable gains from a cost basis of $6.50. Longer-term my guess is that pavm is not a hold. They are turning into an early stage incubator that will burn through cash and require additional funding.
1 · Reply
BigJuicy
BigJuicy May. 11 at 4:33 AM
$PAVM this Thursday or next Thursday?
1 · Reply
chuckjackson
chuckjackson May. 10 at 1:59 PM
4 · Reply
chuckjackson
chuckjackson May. 9 at 3:34 PM
$LUCD only 3 more trading days before we might get the draft lcd or we will be listening to Lishan give us an update of when to expect the draft. If I were to look at this with the glass half full, moidx has already communicated to lucd that they are releasing the draft. Pavm has recently (within the past week or so) changed their investor relations page to increase the number of shares to 11.88M which is an increase of about 4.61M shares. Pavm has indicated they will force the conversion of warrants into 4.61M shares if they receive the draft lcd. $PAVM
3 · Reply
BigJuicy
BigJuicy May. 8 at 11:28 PM
$PAVM power time. Let’s get to 50$
1 · Reply
chuckjackson
chuckjackson May. 7 at 5:46 AM
$PAVM $LUCD this is the screen capture from 4/10 which indicates there were only 6.38M shares
0 · Reply
chuckjackson
chuckjackson May. 7 at 5:39 AM
$PAVM $LUCD has the draft lcd been released. Pavm website indicates there are 11.88M shares. This is possible only if the draft lcd is issued when enables them to force the conversion of warrants?
2 · Reply
Felaw
Felaw May. 7 at 4:48 AM
0 · Reply
chuckjackson
chuckjackson May. 6 at 8:29 PM
$PAVM really bogus. They dropped this by $0.50 on 1k volume
0 · Reply
Investor_Scale
Investor_Scale May. 6 at 5:22 PM
$PAVM waiting patienly for 6-6.5
2 · Reply